home / stock / abvc / abvc news

ABVC News and Press, ABVC BioPharma Inc. From 03/14/24

Stock Information
Company Name: ABVC BioPharma Inc.
Stock Symbol: ABVC
Market: NASDAQ
Website: abvcpharma.com
Menu
ABVC ABVC Quote ABVC Short ABVC News ABVC Articles ABVC Message Board
Get ABVC Alerts

News, Short Squeeze, Breakout and More Instantly...
ABVC - ABVC BioPharma Reports Annual 2023 Financials and Provides Fiscal Year 2024 First Quarter Business Update

FREMONT, CA, March 14, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- ABVC BioPharma, Inc. (NASDAQ: ABVC) (“Company”), a biotechnology company specializing in botanically based solutions that deliver high efficacy and low toxicity to improve health outcomes, announced its 2023 ann...
ABVC - ABVC's New Horizon for Oncology and Hematology Aims at Cancer Market of Several Hundred Billion Dollars

FREMONT, CA - ( NewMediaWire ) - February 27, 2024 -   ABVC BioPharma, Inc.  (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in ophthalmology, CNS (central nervous systems), and oncology/hematology, today provided an upda...

ABVC - ABVC BioPharma Executes a Definitive Agreement to Receive License Fees of $3M and Royalties of 2% on Future Revenues

FREMONT, CA  - ( NewMediaWire ) - February 15, 2024 -  ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in Oncology/Hematology, Neurology, and Ophthalmology, announced today that it signed a definitive agree...

ABVC - ABVC BioPharma Receives Australian Patent, Valid Until 2040, for Its Treatment of Major Depressive Disorder (MDD)

FREMONT, CA , Feb. 12, 2024 (GLOBE NEWSWIRE) -- The Company holds a U.S. patent for the same treatment via NewMediaWire – ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in ophthalmology, neurolo...
ABVC - ABVC Acquires $2.96 Million Worth of Land in Asia with Stocks Priced at $3.50 per Share

FREMONT, CA, Feb. 08, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in Oncology/Hematology, Neurology, and Ophthalmology, announced today that it signed a defi...

ABVC - ABVC BioPharma files to sell 10.4M shares for holders

2024-01-12 17:08:09 ET More on ABVC BioPharma ABVC Biopharma and unit receive $460M as first milestone payment; shares jump For further details see: ABVC BioPharma files to sell 10.4M shares for holders

ABVC - OGEN, RLMD and ATXI among mid-day movers

2024-01-04 12:34:16 ET More on Mid-day movers & Stocks. Relmada Therapeutics, Inc. (RLMD) Q3 2023 Earnings Call Transcript Relmada And REL-1017: Intriguing Underlying Efficacy In MDD Ahead Of Eventful 2024 Avenue Therapeutics GAAP EPS of $0.06 beats by $0.32 ...
ABVC - Opko Health, LifeMD among healthcare movers

2024-01-04 10:00:14 ET More on Health Care Select Sector SPDR XLV Likely Back To Outperforming XLV: Considering The Low-Maintenance Option To Navigate The Healthcare Sector Covid-vaccine makers top laggard list, LLY and WST top gainers list Healthcare and uti...

ABVC - NEXI, MTC and MOLN among pre-market losers

2024-01-04 08:31:40 ET Losers: Mobileye Global ( MBLY ) -27% releases preliminary FY2023 financial results and initial 2024 outlook . Opko Health OPK -16% commences private offering of convertible senior notes . Neximmune ( NEXI ) -16% . Mmtec (...

ABVC - 2 for 2- 24/7 Market News Wrap 3 Jan 2024

2024-01-03 19:51:02 ET DENVER, Colo., Jan. 3, 2024 ( www.247marketnews.com )- 24/7 Market News covered the following companies today; ABVC BioPharma, Inc. (NASDAQ: ABVC), Neximmune Inc (NASDAQ: NEXI), Sidus Space Inc (NASDAQ: SIDU), Voyager Therapeutics Inc (NASDAQ: VYGR), and Cingulate...
Previous 10 Next 10